Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2018

1686  University of Houston  (75504)

Principal Investigator: Kevin W Garey

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 564,375

Exceeds $250,000 (Is it flagged?): Yes

Start and End Dates: 8/1/17 - 7/31/22

Restricted Research: YES

Academic Discipline: PHARM PRAC & TRANS RESEARCH

Department, Center, School, or Institute: DEAN, PHARMACY

Title of Contract, Award, or Gift: Relationships Between Metronidazole Resistance, Pharmacodynamics and Treatment Outcomes in Clostridium difficile Infection

Name of Granting or Contracting Agency/Entity: National Institute of Allergy andInfectious Diseases

Program Title: none
CFDA Linked: Biomedical Research and Research Training


1.1.1 - This is an ongoing prospective cohort study of hospitalized patients greater than or equal to 18 years of age. All patients have primary CDI as defined as patients who received an antimicrobial agent during their current hospitalization with diarrhea........and a positive C. difficile toxin assay (PCR or ELISA).

Discussion: No discussion notes


Close Window